Fidaxomicin is a drug specifically used to fight Clostridium difficile infection. Fidaxomicin interferes with the metabolic process of Clostridium difficile, prevents the reproduction and spread of Clostridium difficile, controls infection and improves the patient's diarrhea symptoms. While using Fidaxomicin for treatment, patients also need to pay special attention to some matters, and consult a doctor in time if they feel uncomfortable.
What are the precautions for Fidaxomicin?
When using it, patients should pay attention to the following matters:
Risk of allergic reaction
Fidaxomicin may cause acute allergic reactions, including dyspnea, rash, itching, and angioedema of the mouth, throat and face. These reactions may be caused by abnormal immune responses of individual patients to Fidaxomicin or some of its components. Patients should pay close attention to their physical condition during medication, and seek medical attention as soon as possible if the above allergic symptoms occur.
Limitation of scope of application
Fidaxomicin has low systemic absorption and mainly acts locally in the intestine, which allows it to act directly in the intestine and inhibit the growth of Clostridium difficile. Due to the limited systemic absorption of Fidaxomicin, it may not be effective in treating other types of infections.
Risk of development of drug-resistant bacteria
In the absence of clear or highly suspected C. difficile infection, blind use of Fidaxomicin may not only have no therapeutic effect, but also increase the risk of development of drug-resistant bacteria. Patients should use Fidaxomicin reasonably under the guidance of a doctor and according to the needs of the condition to avoid unnecessary medication.
Fidaxomicin is a prescription drug and must be used reasonably under the guidance of a doctor. Patients should avoid blind medication to avoid increasing the risk of drug-resistant bacteria and take active preventive measures to reduce the possibility of infection.
Usage and dosage of Fidaxomicin
The recommended dose and duration of Fidaxomicin are as follows:
Adult patients
It is recommended to take one 200mg Fidaxomicin tablet orally twice a day for 10 consecutive days. For more information about Fidaxomicin, click for free online consultation
Patients aged 6 months to under 18 years
For patients weighing at least 12.5 kg and able to swallow tablets, the recommended dose is one 200mg Fidaxomicin tablet orally twice a day for 10 consecutive days.
For patients who cannot swallow tablets, Fidaxomicin oral suspension can be selected. The dosage of the oral suspension is based on the patient's weight, and the patient takes Fidaxomicin suspension orally twice a day for 10 days.
Whether using tablets or oral suspension, patients should follow the doctor's instructions, take it on time and in the right amount, and do not adjust the dose or stop the medication on their own. Pay attention to the physical reaction during medication, and seek medical attention in time if there is any abnormality.
